Choi MoonHyeok ChoiMoonHyeok

Choi MoonHyeok ChoiMoonHyeok


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2026 in Bioengineering
Verified
Journal Article
Open access
PDF file
CCChoi MoonHyeok ChoiMoonHyeok
Choi MoonHyeok ChoiMoonHyeok
JJJaehyun Jo
Jaehyun Jo
JJJin-Hyoung Jeong
Jin-Hyoung Jeong
Parkinson’s disease (PD) is associated with progressive gait deterioration; however, widely used clinical scales such as the Hoehn & Yahr (H&Y) stage are limited in capturing continuous severity changes due to subjectivity and discrete grading. This study proposes a two-stage explainable AI framework using vertical ground reaction force (VGRF) signals to achieve reproducible PD detection and continuous severity estimation. In the first stage, three deep learning models, temporal convolutional network (TCN), BiGRU with attention, and FCNN-Transformer, were trained using windowed VGRF signals under repeated subject-wise data segmentation. All models achieved high discrimination performance (AUC ≥ 0.93), with FCNN-Transformer showing the highest mean AUC (0.940) and statistically superior performance (paired Wilcoxon test, p < 0.05). Stability-based explainable AI using Integrated Gradients consistently identified variability-related VGRF features as the most informative, which were also significantly different between groups at the data level (p < 0.001, FDR-corrected). In the second stage, XGBoost regression was applied to PD subjects to predict continuous H&Y severity, achieving strong correlation with clinical grades (Spearman ρ = 0.921, p < 0.001), low error (MAE = 0.158, RMSE = 0.241), and high determination (R2 = 0.953). This shows that gait-based features are a sensitive enough signal to continuously quantify disease progression. In addition, in the TREND prospective longitudinal cohort (n = 696), wearable walking indicators differed significantly from those of non-patients prior to diagnosis, and a decline in walking pace was observed approximately four years before Parkinson’s disease diagnosis, providing the basis for early screening and monitoring using gait-based digital biomarkers. These results demonstrate that gait-based digital biomarkers can objectively quantify both PD presence and disease progression. The proposed framework provides a reproducible, explainable, and clinically interpretable AI-based decision support approach for PD assessment.

10 March 2026 in Life
Verified
Journal Article
Open access
PDF file
CCChoi MoonHyeok ChoiMoonHyeok
Choi MoonHyeok ChoiMoonHyeok
JJJaehyun Jo
Jaehyun Jo
JJJin-Hyoung Jeong
Jin-Hyoung Jeong
The primary objective of this study was to evaluate the relative contributions of the MMSE and nWBV in three-class cognitive stage classification, with a secondary objective of conducting a subgroup analysis to investigate latent risk within the MMSE-normal population. To achieve this, we proposed an explainable deep-learning-based analytical framework integrating the MMSE with nWBV, a structural brain atrophy indicator, and systematically assessed the relative contributions of each variable in cognitive impairment stage classification and potential risk screening. Although the MMSE is widely used in clinical practice as a cognitive screening tool, it has limited sensitivity to early or subtle cognitive decline and may not adequately reflect structural brain changes due to the ceiling effect. To address this limitation, we compared four tabular deep learning models—MLP, Tab ResNet, Tab Transformer, and FT Transformer—under identical fivefold cross-validation conditions. Age and sex were fixed as covariates, and feature ablation analysis was conducted to examine the independent and combined effects of the MMSE and nWBV. The results showed no statistically significant differences in classification performance among model architectures, indicating that predictive performance was primarily determined by the informational content of the input variables rather than model complexity. In the feature ablation analysis, the MMSE alone demonstrated strong discriminative power, whereas nWBV alone showed relatively limited performance; however, when combined with the MMSE, nWBV consistently improved classification performance. Furthermore, for interpretability analysis, both Integrated Gradients (IG) and SHAP were applied to validate variable contributions from complementary perspectives. Across both methods, the MMSE and nWBV were repeatedly identified as key contributing features, and interpretability stability was maintained throughout cross-validation folds, supporting the robustness and reliability of the explanatory results. Beyond simple model performance comparisons, this study provides evidence supporting the complementary integration of structural brain atrophy information into MMSE-centered traditional cognitive assessment by jointly considering variable contribution and interpretability stability. This approach is expected to contribute to precision risk screening and clinical decision support in the early stages of cognitive decline. Although the MMSE exhibited strong discriminative performance, nWBV provided complementary structural risk signals within the MMSE-normal subgroup, suggesting that integrating cognitive assessment with structural biomarkers may enhance early risk identification.

12 June 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
CCChoi MoonHyeok ChoiMoonHyeok
Choi MoonHyeok ChoiMoonHyeok
JJJaehyun Jo
Jaehyun Jo
JJJin-Hyoung Jeong
Jin-Hyoung Jeong
Background/Objectives: Depression, anxiety disorders, and substance use disorders frequently coexist in clinical settings and are main factors that worsen a patient’s prognosis. However, traditional artificial intelligence-based mental health studies have limitations in capturing the complex symptoms that occur in actual counseling situations by relying on social media data or focusing on binomial classification of single diseases. This study proposes a multi-label classification model that simultaneously detects the coexistence of depression, anxiety, and substance use disorder in actual counseling dialogue texts, and applies the Shapley Additive Explanatory (SHAP) method to explain the clinical basis of model prediction. Methods: We retrospectively analyzed 1661 de-identified Korean-language counseling session transcripts obtained from the publicly available AI Hub “Mental Health Counseling Dialogue” dataset (Republic of Korea; sessions collected between 2021 and 2023 from accredited domestic mental health counseling centers). Each session averaged 30 min (≈5000 Korean characters). Labeling was performed by two licensed clinical psychologists (inter-rater Cohen’s κ = 0.82). A Hierarchical Attention Network with Bidirectional LSTM (HAN-BiLSTM) was constructed; performance was compared with six baselines (Flat LSTM, TextCNN, KR-BERT, KoBERT, KoELECTRA, KLUE-RoBERTa) using stratified 5-fold cross-validation, paired t-tests with Bonferroni correction, and McNemar’s test. Top-ranked SHAP tokens were independently rated for clinical face validity by three psychiatrists. Results: The proposed model outperformed the baseline model not only for the labels of depression (F1 = 0.90) and anxiety (F1 = 0.85) but also for substance use disorder (F1 = 0.78) with poor data, achieving a macro-averaged F1 of 0.84 (95% CI 0.82–0.86; all p < 0.001 versus baselines). As a result of the SHAP analysis, clinically significant keywords such as “I want to die,” “anxiety,” and “drink” were identified as the model’s main basis for judgment, accurately tracking the client’s state, which dynamically changed as the dialogue progressed; three independent psychiatrists rated 88.7% of the top-15 SHAP tokens per label as clinically meaningful (Fleiss’s κ = 0.76). Conclusions: This study demonstrated that a deep learning-based multi-label approach is effective in early screening of complex mental health problems. In particular, the introduction of explainable AI (XAI) increases clinicians’ trust and suggests that it can be used as an AI-based clinical decision support system (CDSS) in the future.